We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$148M
2
HUM icon
Humana
HUM
+$109M
3
META icon
Meta Platforms (Facebook)
META
+$102M
4
MSI icon
Motorola Solutions
MSI
+$89.2M
5
LOW icon
Lowe's Companies
LOW
+$82M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHX
101
DELISTED
ChampionX
CHX
$39.1M 0.26%
4,001,605
+3,926,071
+5,198% +$36M
TSM icon
102
TSMC
TSM
$2.18T
$39M 0.26%
686,593
+574,350
+512% +$30.3M
UTHR icon
103
United Therapeutics
UTHR
$23.1B
$38.5M 0.25%
318,336
+287,192
+922% +$32.3M
CNQ icon
104
Canadian Natural Resources
CNQ
$93.8B
$38.2M 0.25%
+4,509,630
New +$36.4M
CI icon
105
Cigna
CI
$74.6B
$38M 0.25%
202,714
-135,225
-40% -$25.7M
WRK
106
DELISTED
WestRock Company
WRK
$37M 0.24%
1,309,732
+1,176,159
+881% +$33.4M
XEC
107
DELISTED
CIMAREX ENERGY CO
XEC
$35.6M 0.24%
1,294,643
+1,277,745
+7,562% +$31.7M
ADI icon
108
Analog Devices
ADI
$190B
$35.6M 0.24%
290,149
-121,357
-29% -$13.3M
MPLX icon
109
MPLX
MPLX
$59.7B
$35.4M 0.23%
2,050,897
+1,675,680
+447% +$28.6M
ECL icon
110
Ecolab
ECL
$79.9B
$35M 0.23%
175,751
+34,065
+24% +$6.6M
TSN icon
111
Tyson Foods
TSN
$20.4B
$34.4M 0.23%
576,040
+540,247
+1,509% +$32.7M
CVS icon
112
CVS Health
CVS
$122B
$34.1M 0.23%
525,080
-823,410
-61% -$51.9M
REGN icon
113
Regeneron Pharmaceuticals
REGN
$80.8B
$34M 0.22%
54,475
+43,413
+392% +$24.6M
GBT
114
DELISTED
Global Blood Therapeutics, Inc.
GBT
$33.8M 0.22%
535,276
+450,108
+528% +$30.9M
LRCX icon
115
Lam Research
LRCX
$390B
$33.7M 0.22%
1,040,760
-1,517,870
-59% -$41.4M
WWE
116
DELISTED
World Wrestling Entertainment
WWE
$33.5M 0.22%
770,025
-284,002
-27% -$12.2M
MYOK
117
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$33.2M 0.22%
343,783
+39,188
+13% +$3.27M
NVR icon
118
NVR
NVR
$17B
$32.7M 0.22%
10,031
-4,178
-29% -$12.8M
SHW icon
119
Sherwin-Williams
SHW
$89.8B
$32.5M 0.21%
168,759
-25,359
-13% -$4.57M
PE
120
DELISTED
PARSLEY ENERGY INC
PE
$32.4M 0.21%
+3,030,863
New +$28.1M
PTC icon
121
PTC
PTC
$16B
$32.3M 0.21%
415,582
-587,624
-59% -$41.6M
CSL icon
122
Carlisle Companies
CSL
$15.4B
$32.1M 0.21%
+267,879
New +$32.2M
JNJ icon
123
Johnson & Johnson
JNJ
$625B
$32M 0.21%
227,246
-1,300,748
-85% -$190M
FWONK icon
124
Liberty Media Series C
FWONK
$25.8B
$31.5M 0.21%
1,025,945
+1,018,949
+14,565% +$30.3M
DD icon
125
DuPont de Nemours
DD
$19.2B
$30.8M 0.2%
461,297
-602,169
-57% -$35.2M
3 4
5
6 7

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.